Fluoxetine alleviates behavioral depression while decreasing acetylcholine release in the nucleus accumbens shell

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Selective serotonin reuptuptake inhibitors (SSRIs) alleviate depression but their mechanisms are unclear.
• Acetylcholine (ACh) acting on M1 receptors in the nucleus accumbens (NAc) shell may mediate depression behaviors.

Purpose of the Study:

• To investigate if fluoxetine reduces depression behaviors by lowering ACh in the NAc shell.
• To examine acute and chronic fluoxetine effects on escape motivation and ACh levels.

Main Methods:

• Fluoxetine was administered acutely and chronically in rats undergoing the forced swim test.
• Extracellular ACh levels in the NAc shell were measured.
• Locomotor activity was assessed in an open field test.

Main Results:

• Acute fluoxetine infusion into the NAc shell reduced ACh and increased swimming.
• Bilateral NAc fluoxetine infusions dose-dependently decreased immobility and increased escape attempts.
• Chronic systemic fluoxetine reduced immobility and increased escape attempts, with normalized ACh levels post-treatment.

Conclusions:

• Fluoxetine's antidepressant effects in the forced swim test may involve suppressing cholinergic activity in the NAc shell.
• These findings elucidate a potential neurochemical mechanism for SSRI action in depression.